Masco Corp.: Investor Day Takeaways

Research evidence excerpt

Masco Corp.: Investor Day Takeaways

Equity Research

U.S. Homebuilding & Building Products

13 May 2026

Masco Corp.

Investor Day Takeaways

Modestly altered 2028 targets are fairly realistic in our

eyes, and we think the reinforcement of steadfast long-term

objectives and continued brand dominance leave the stock MAS EQUAL WEIGHT U.S. Homebuilding &

Building Productsstill defensively positioned in today's volatile end market POSITIVE

Price Target USD 78.00

backdrop. Price (13-May-26) USD 67.48

Potential Upside/Downside +15.6%

Source: Bloomberg, Barclays Research

The reaction in the stock today (MAS -3% vs. S&P +1%) suggests some investors may have

expected an increase to the LT growth algorithm, or perhaps some skepticism on the new

margin targets, but we do not think that any increase to growth expectations would have U.S. Homebuilding & Building

been very realistic in today's world, even as MAS outlines and defines several intriguing Products

growth strategies. Accordingly, a consistent +10% annual EPS growth target is entirely in- Matthew Bouley

line with our own expectations, even as MAS made slight tweaks to the underlying +1 212 526 9029

matthew.bouley@barclays.comalgo that perhaps suggests productivity and positive price-cost need to be a touch better

BCI, US

given a slight growth reduction. Overall, we thought the financial targets were a neutral

read, and we don't punish the company for assuming a modest return to market growth in Elizabeth Langan

2027 to support a reasonable +10% EPS growth. +1 212 526 5960

elizabeth.langan@barclays.com

Organic growth is now guided to +3-4% through 2028 (down slightly from prior 3-5%), with MAS BCI, US

now more implicitly assuming LSD% growth and +1-2% market outgrowth. This came with Anika Dholakia